Delivery Order SPE2DB22D1106-SPE2DB24FDXD1
- Not listed
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a $7,319.44 delivery order for the pharmaceutical product Advair HFA 230-21 MCG Inhaler 12GM. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of April 11, 2024. The contract is a firm-fixed-price delivery order with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant $999,999,999...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $13,505.54 and an ultimate completion date of January 26, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type. The award was made without a set-aside designation, indicating open competition....
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $20,165.89 for Advair HFA 230-21 MCG Inhaler 12GM. The contract is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA), a defense agency. The ultimate completion date is May 1, 2024. This award is not associated with a set-aside program and was competed openly. Amerisourcebergen is a major pharmaceutical distributor that holds significant Indefinite...
- This federal contract award, issued by the Defense Logistics Agency (DLA), is a delivery order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Advair HFA 230-21 MCG Inhaler 12GM. The $21,793.70 firm fixed price delivery order has a completion date of February 5, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a...
- The federal contract award is to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the delivery of Advair HFA 115-21 MCG Inhaler 12GM to the Defense Logistics Agency (DLA). The Firm Fixed Price delivery order, valued at $4,701.81, has an ultimate completion date of March 1, 2024. This contract is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The IDC enables...
- This federal contract award, valued at $17,822.29, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of Advair HFA 230-21 MCG Inhaler, a pharmaceutical product, with a completion date of May 7, 2024. The contract type is a Delivery Order, with a Firm Fixed Price pricing mechanism. This award is not designated as a set-aside contract. Amerisourcebergen Drug Corp, a major pharmaceutical distributor, has a...
- This is a federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $4,191.15, is for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product. The contract is a Delivery Order with a Firm Fixed Price pricing type and has a completion date of May 6, 2024. The award was made on May 3, 2024, and there is no set-aside designation. Amerisourcebergen Drug Corp holds a...
- This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Advair HFA 230-21 MCG inhalers. The $1,688.82 firm-fixed-price contract has an ultimate completion date of August 17, 2021. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
- This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., was issued by the Defense Logistics Agency (DLA) under a Delivery Order valued at $6,654.52. The contract provides for the delivery of Advair HFA 115-21 MCG Inhaler 12GM, a pharmaceutical product, with a period of performance through February 28, 2024. The contract is a Firm Fixed Price type and was awarded without a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp...
- This federal contract award, with ID SPE2DX15D1053|SPE2DX24F6GNX, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The $7,500.53 firm fixed-price delivery order is for the supply of the pharmaceutical product Advair HFA 115-21 MCG Inhaler 12GM. The contract has an ultimate completion date of February 13, 2024. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FDXD1Delivery Order
This federal contract award is a delivery order worth $7,315.86 issued to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., by the Defense Logistics Agency (DLA). The award is for the delivery of Advair HFA 115-21 mcg inhalers, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of January 26, 2024 and is a firm fixed-price delivery order. There is no set-aside designation for this award. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support the Department of Defense's healthcare needs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000, for similar medical products and prescription drugs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.3k | 1/25/24 |